What is the brand name of Esketamine?

The brand name of Esketamine is Spravato. Esketamine is a derivative of ketamine and is used primarily for the treatment of treatment-resistant depression. Spravato is administered as a nasal spray and has been found to provide rapid antidepressant effects, which is significant for individuals who have not responded to traditional antidepressant therapies.

Spravato’s approval by regulatory agencies highlights its unique mechanism of action and its importance in a clinical setting. The other listed names do not correspond to Esketamine; instead, they may refer to different medications or formulations not related to the treatment of depression. Sesamet, for example, is related to a different context, whereas Ketoril refers to ketorolac, a non-steroidal anti-inflammatory drug, which is not relevant in this context. Thus, Spravato is the correct association for Esketamine in the treatment of mental health conditions.